Notice of Results

8 February 2019

Circassia Pharmaceuticals plc

Notice of Preliminary Results

Circassia Pharmaceuticals plc (LSE: CIR) will announce its preliminary results for the year ended 31 December 2018 on Wednesday 1 May 2019.

A presentation for analysts will take place at the offices of FTI Consulting, 200 Aldersgate, Aldersgate Street, London, EC1A 4HD at 9.30am. A webcast of the presentation will be available on the Company's website.

Contacts

Circassia

Steve Harris, Chief Executive Officer Tel: +44 (0) 1865 405 560

Julien Cotta, Chief Financial Officer

Rob Budge, Corporate Communications

Peel Hunt (Nominated Adviser and Joint Broker)

James Steel / Dr Christopher Golden Tel: +44 (0) 20 7418 8900

Numis Securities (Joint Broker)

James Black / Freddie Barnfield Tel: +44 (0) 20 7260 1000

FTI Consulting

Simon Conway / Ciara Martin Tel: +44 (0) 20 3727 1000